Li‐Jian Liang

A novel and accurate predictor of survival for patients with hepatocellular carcinoma after surgical resection: the neutrophil to lymphocyte ratio (NLR) combined with the aspartate aminotransferase/platelet count ratio index (APRI)

Fei Ji, Yao Liang, Shunjun Fu et al. · BMC Cancer · 2016 · 109 citations · Full text

Medicine, Oncology, Pathology +17

Preoperative Aspartate Aminotransferase to Platelet Ratio is an Independent Prognostic Factor for Hepatitis B-Induced Hepatocellular Carcinoma After Hepatic Resection

Shunli Shen, Shunjun Fu, Bin Chen et al. · Annals of Surgical Oncology · 2014 · 104 citations

Medicine, Hematology, Oncology +15

Efficacy and Safety of the FOLFOX4 Regimen Versus Doxorubicin in Chinese Patients With Advanced Hepatocellular Carcinoma: A Subgroup Analysis of the EACH Study

Shukui Qin, Ying Cheng, Jun Liang et al. · The Oncologist · 2014 · 100 citations · Full text

Medicine, Oncology, Pharmacology +14

Is Salvage Liver Resection Necessary for Initially Unresectable Hepatocellular Carcinoma Patients Downstaged by Transarterial Chemoembolization? Ten Years of Experience

Yingqiang Zhang, Guihua Huang, Yu Wang et al. · The Oncologist · 2016 · 88 citations · Full text

Medicine, Oncology, Surgery +11

Glypican-3 is a potential prognostic biomarker for hepatocellular carcinoma after curative resection

Shunjun Fu, Chao-Ying Qi, Weikai Xiao et al. · Surgery · 2013 · 85 citations

Medicine, Oncology, Pharmacology +16